CRISPR Therapeutics AG (CRSP) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "CRSP"
      ],
      "issuer_cik": "0001674416",
      "owner_cik": "0001595117",
      "accession_number": "0001193125-26-424317",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-14",
      "issuer_name": "CRISPR Therapeutics AG",
      "issuer_trading_symbol": "CRSP",
      "owner_name": "George Simeon",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-14",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 14514,
      "transaction_price_per_share": 49.633,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 15486,
      "transaction_value": 720373.3620000001,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."
        },
        {
          "id": "F2",
          "description": "The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.45 to $50.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
        }
      ]
    },
    {
      "tickers": [
        "CRSP"
      ],
      "issuer_cik": "0001674416",
      "owner_cik": "0001708172",
      "accession_number": "0001193125-26-418101",
      "form_type": "4",
      "filing_date": "2026-10-08",
      "period_of_report": "2026-10-06",
      "issuer_name": "CRISPR Therapeutics AG",
      "issuer_trading_symbol": "CRSP",
      "owner_name": "KASINGER JAMES R.",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "General Counsel and Secretary",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-06",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 1990,
      "transaction_price_per_share": 60.0408,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 94784,
      "transaction_value": 119481.192,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.